How should a 75-year-old female patient with tachycardia be initially managed in the emergency room?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tachycardia in a 75-Year-Old Female in the Emergency Room

For a 75-year-old female with tachycardia (heart rate 120 bpm) in the emergency room, immediate assessment of hemodynamic stability is essential, followed by IV fluid administration, laboratory testing, and cardiology consultation while preparing for hospital admission.

Initial Assessment and Stabilization

Assess Hemodynamic Stability

  • Evaluate for signs of instability 1:
    • Altered mental status
    • Ischemic chest pain
    • Acute heart failure
    • Hypotension
    • Signs of shock

Immediate Interventions

  • Administer supplemental oxygen if oxygen saturation is inadequate 1
  • Establish IV access (already planned)
  • Begin IV fluid administration (already planned)
  • Obtain 12-lead ECG to better define the rhythm 1, 2
  • Continuous cardiac monitoring

Diagnostic Workup

Laboratory Testing

  • Complete blood count to evaluate for anemia 2
  • Electrolytes (particularly potassium and magnesium)
  • Thyroid function tests to rule out hyperthyroidism 2
  • Cardiac biomarkers (troponin)
  • Arterial blood gas if respiratory compromise is suspected 2

Additional Diagnostic Tests

  • Echocardiography to evaluate cardiac structure and function 2
  • Chest X-ray to evaluate for pulmonary causes

Treatment Approach Based on Rhythm Classification

If Narrow-Complex Tachycardia

  1. If hemodynamically unstable: Proceed with immediate synchronized cardioversion 1

  2. If hemodynamically stable:

    • First try vagal maneuvers (Valsalva) 1
    • If vagal maneuvers fail, administer adenosine:
      • Initial dose: 6 mg rapid IV push followed by saline flush
      • If no response after 1-2 minutes: 12 mg 1
    • For atrial fibrillation with rapid ventricular response:
      • Beta-blockers (e.g., metoprolol) or diltiazem are first-line agents 1
      • Avoid AV nodal blocking agents in pre-excited atrial fibrillation 1

If Wide-Complex Tachycardia

  1. If hemodynamically unstable: Immediate synchronized cardioversion 1

  2. If hemodynamically stable:

    • Regular wide-complex tachycardia: Consider amiodarone 150 mg IV over 10 minutes, followed by maintenance infusion of 1 mg/min for 6 hours 1, 2
    • If ventricular tachycardia is suspected, avoid adenosine unless the rhythm is regular and monomorphic 1

If Sinus Tachycardia

  • Identify and treat the underlying cause (e.g., fever, anemia, hypotension, dehydration) 1
  • IV fluid administration is appropriate for volume depletion
  • Beta-blockers may be considered if no contraindications exist 2

Special Considerations for Elderly Patients

  • Start with lower doses of medications due to potential for decreased hepatic, renal, or cardiac function 3
  • Monitor closely for adverse effects of medications
  • Be aware of potential drug interactions with existing medications

Potential Complications of Untreated Tachycardia

  • Tachycardia-induced cardiomyopathy if persistent 2, 4, 5
  • Neurological complications including syncope 6
  • Worsening heart failure 4

Common Pitfalls to Avoid

  • Misdiagnosing wide-complex tachycardia as SVT 2
  • Using AV nodal blockers in pre-excited atrial fibrillation, which can accelerate ventricular rate 1, 2
  • Failing to identify and treat underlying causes, leading to recurrence 2
  • Administering verapamil if beta-blockers have been taken due to risk of profound bradycardia and hypotension 1

The cardiology consultation and hospital admission are appropriate next steps for this elderly patient with tachycardia, as they will allow for continuous monitoring, comprehensive evaluation, and specialized management of the arrhythmia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiovascular and Respiratory Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tachycardia-induced heart failure.

The Permanente journal, 2007

Research

Tachyarrhythmias and neurologic complications.

Handbook of clinical neurology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.